Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Simvastatin Reduces Plasma Osteoprotegerin in Type 2 Diabetic Patients With Microalbuminuria

NCT00471549 is registered in ClinicalTrials.gov with University of Aarhus as lead sponsor.

NCT NCT00471549
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00471549 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Simvastatin Reduces Plasma Osteoprotegerin in Type 2 Diabetic Patients With Microalbuminuria
Lead sponsor
University of Aarhus
Phase
Phase 4
Overall status
Completed
Start date
June 30, 1991
Completion date
December 31, 1993
Enrollment
18 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes